Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The effect of glucagon-like peptide-1 and glucagon-like peptide-2 on microcirculation: a systematic review

Research output: Contribution to journalReviewResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{63830c9eb2a74f0589a13f5e09d9ff97,
title = "The effect of glucagon-like peptide-1 and glucagon-like peptide-2 on microcirculation: a systematic review",
abstract = "GLP-1 and GLP-2 are gut-derived hormones used in the treatment of diabetes type-2 and short bowel syndrome, respectively. GLP-1 attenuates insulin resistance and GLP-2 reduces enterocyte apoptosis and enhances crypt cell proliferation in the small intestine. In addition, both hormones have vasoactive effects and may be useful in situations with impaired microcirculation. The aim of this systematic review was to provide an overview of the potential effects of GLP-1 and GLP-2 on microcirculation. A systematic search was performed independently by two authors in the following databases: PubMed, EMBASE, Cochrane library, Scopus, and Web of Science. Of 1111 screened papers, 20 studies were included in this review: 16 studies in animals, three in humans, and one in humans and rats. The studies were few and heterogeneous and had a high risk of bias. However, it seems that GLP-1 regulates the pancreatic, skeletal, and cardiac muscle flow, indicating a role in the glucose homeostasis, while GLP-2 acts primarily in the regulation of the microcirculation of the mid-intestine. These findings may be useful in gastrointestinal surgery and in situations with impaired microcirculation of the gut.",
keywords = "Journal Article, Review, glucagon-like peptide-2, glucagon-like peptide-1, systematic review, microcirculation",
author = "Nikolaj Nerup and Rikard Ambrus and Joanna Lindhe and Achiam, {Michael P} and Jeppesen, {Palle B} and Svendsen, {Lars B}",
note = "{\circledC} 2017 John Wiley & Sons Ltd.",
year = "2019",
doi = "10.1111/micc.12367",
language = "English",
volume = "26",
pages = "e12367",
journal = "Microcirculation Review",
issn = "0168-1745",
publisher = "Springer Netherlands",
number = "3",

}

RIS

TY - JOUR

T1 - The effect of glucagon-like peptide-1 and glucagon-like peptide-2 on microcirculation

T2 - a systematic review

AU - Nerup, Nikolaj

AU - Ambrus, Rikard

AU - Lindhe, Joanna

AU - Achiam, Michael P

AU - Jeppesen, Palle B

AU - Svendsen, Lars B

N1 - © 2017 John Wiley & Sons Ltd.

PY - 2019

Y1 - 2019

N2 - GLP-1 and GLP-2 are gut-derived hormones used in the treatment of diabetes type-2 and short bowel syndrome, respectively. GLP-1 attenuates insulin resistance and GLP-2 reduces enterocyte apoptosis and enhances crypt cell proliferation in the small intestine. In addition, both hormones have vasoactive effects and may be useful in situations with impaired microcirculation. The aim of this systematic review was to provide an overview of the potential effects of GLP-1 and GLP-2 on microcirculation. A systematic search was performed independently by two authors in the following databases: PubMed, EMBASE, Cochrane library, Scopus, and Web of Science. Of 1111 screened papers, 20 studies were included in this review: 16 studies in animals, three in humans, and one in humans and rats. The studies were few and heterogeneous and had a high risk of bias. However, it seems that GLP-1 regulates the pancreatic, skeletal, and cardiac muscle flow, indicating a role in the glucose homeostasis, while GLP-2 acts primarily in the regulation of the microcirculation of the mid-intestine. These findings may be useful in gastrointestinal surgery and in situations with impaired microcirculation of the gut.

AB - GLP-1 and GLP-2 are gut-derived hormones used in the treatment of diabetes type-2 and short bowel syndrome, respectively. GLP-1 attenuates insulin resistance and GLP-2 reduces enterocyte apoptosis and enhances crypt cell proliferation in the small intestine. In addition, both hormones have vasoactive effects and may be useful in situations with impaired microcirculation. The aim of this systematic review was to provide an overview of the potential effects of GLP-1 and GLP-2 on microcirculation. A systematic search was performed independently by two authors in the following databases: PubMed, EMBASE, Cochrane library, Scopus, and Web of Science. Of 1111 screened papers, 20 studies were included in this review: 16 studies in animals, three in humans, and one in humans and rats. The studies were few and heterogeneous and had a high risk of bias. However, it seems that GLP-1 regulates the pancreatic, skeletal, and cardiac muscle flow, indicating a role in the glucose homeostasis, while GLP-2 acts primarily in the regulation of the microcirculation of the mid-intestine. These findings may be useful in gastrointestinal surgery and in situations with impaired microcirculation of the gut.

KW - Journal Article

KW - Review

KW - glucagon-like peptide-2

KW - glucagon-like peptide-1

KW - systematic review

KW - microcirculation

UR - http://www.scopus.com/inward/record.url?scp=85064343648&partnerID=8YFLogxK

U2 - 10.1111/micc.12367

DO - 10.1111/micc.12367

M3 - Review

VL - 26

SP - e12367

JO - Microcirculation Review

JF - Microcirculation Review

SN - 0168-1745

IS - 3

ER -

ID: 52372614